Total Payments
$3,057
2024 Payments
$216.52
Companies
8
Transactions
172
Medicare Patients
7,247
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$2,734 (89.4%)
Gifts$323.77 (10.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,734 | 168 | 89.4% |
| Gift | $323.77 | 4 | 10.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ferring Pharmaceuticals Inc. | $1,028 | 61 | $0 (2022) |
| ABBVIE INC. | $515.29 | 29 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $513.18 | 36 | $0 (2024) |
| Braintree Laboratories, Inc. | $449.83 | 13 | $0 (2024) |
| Allergan, Inc. | $394.68 | 30 | $0 (2020) |
| Gilead Sciences, Inc. | $125.00 | 1 | $0 (2019) |
| Medtronic USA, Inc. | $16.73 | 1 | $0 (2017) |
| Novo Nordisk Inc | $14.40 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $216.52 | 5 | Braintree Laboratories, Inc. ($180.96) |
| 2023 | $156.09 | 7 | Braintree Laboratories, Inc. ($156.09) |
| 2022 | $392.77 | 18 | Ironwood Pharmaceuticals, Inc ($144.92) |
| 2021 | $365.48 | 17 | Ferring Pharmaceuticals Inc. ($138.76) |
| 2020 | $284.99 | 26 | IRONWOOD PHARMACEUTICALS, INC ($143.10) |
| 2019 | $572.55 | 29 | Ironwood Pharmaceuticals, Inc ($162.23) |
| 2018 | $397.18 | 31 | Ferring Pharmaceuticals Inc. ($157.51) |
| 2017 | $671.81 | 39 | Ferring Pharmaceuticals Inc. ($367.69) |
All Payment Transactions
172 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/10/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.09 | General |
| Category: GI | ||||||
| 08/22/2024 | Braintree Laboratories, Inc. | SUTAB (Drug) | Gift | Cash or cash equivalent | $81.81 | General |
| Category: GI COLON PREP | ||||||
| 08/22/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Gift | Cash or cash equivalent | $81.81 | General |
| Category: GI COLON PREP | ||||||
| 03/15/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: GI COLON PREP | ||||||
| 12/14/2023 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: GI COLON PREP | ||||||
| 10/27/2023 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: GI COLON PREP | ||||||
| 07/07/2023 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: GI COLON PREP | ||||||
| 06/27/2023 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: GI COLON PREP | ||||||
| 03/24/2023 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: GI COLON PREP | ||||||
| 01/31/2023 | Braintree Laboratories, Inc. | SUTAB (Drug) | Gift | Cash or cash equivalent | $79.69 | General |
| Category: GI COLON PREP | ||||||
| 01/30/2023 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: GI COLON PREP | ||||||
| 11/15/2022 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $7.79 | General |
| Category: GI | ||||||
| 10/20/2022 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $108.41 | General |
| Category: GI | ||||||
| 10/06/2022 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/27/2022 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $8.91 | General |
| Category: GI | ||||||
| 07/29/2022 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $8.59 | General |
| Category: GI | ||||||
| 07/23/2022 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/17/2022 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/20/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/13/2022 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/23/2022 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/22/2022 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/15/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: GI COLON PREP | ||||||
| 04/01/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,884 | 2,998 | $1.0M | $264,003 |
| 2022 | 15 | 1,885 | 3,198 | $1.1M | $289,536 |
| 2021 | 16 | 1,914 | 2,985 | $1.2M | $302,608 |
| 2020 | 16 | 1,564 | 2,768 | $955,055 | $247,265 |
Total Patients
7,247
Total Services
11,949
Medicare Billing
$1.1M
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 429 | 858 | $128,700 | $63,252 | 49.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 139 | 773 | $115,950 | $51,178 | 44.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 124 | 125 | $200,000 | $24,741 | 12.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 186 | 186 | $55,800 | $22,168 | 39.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 147 | 157 | $51,025 | $21,959 | 43.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 193 | 198 | $193,050 | $20,701 | 10.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 91 | 97 | $99,425 | $14,273 | 14.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 126 | $22,050 | $12,471 | 56.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 68 | 68 | $13,600 | $9,446 | 69.5% |
| 83013 | Breath test analysis for helicobacter pylori | Office | 2023 | 108 | 113 | $22,600 | $7,459 | 33.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 42 | 42 | $50,400 | $6,620 | 13.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 107 | 112 | $14,000 | $5,153 | 36.8% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2023 | 14 | 15 | $24,000 | $2,484 | 10.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 15 | $12,750 | $1,229 | 9.6% |
| 83014 | Administration of drug for helicobacter pylori | Office | 2023 | 108 | 113 | $3,390 | $870.10 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 408 | 869 | $130,350 | $65,052 | 49.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 156 | 939 | $140,850 | $56,420 | 40.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 165 | 184 | $59,800 | $30,382 | 50.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 131 | 133 | $212,800 | $28,320 | 13.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 210 | 215 | $209,625 | $24,032 | 11.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 172 | 172 | $51,600 | $22,830 | 44.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 162 | $28,350 | $15,826 | 55.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 80 | 82 | $84,050 | $12,717 | 15.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 64 | 64 | $12,800 | $9,444 | 73.8% |
| 83013 | Breath test analysis for helicobacter pylori | Office | 2022 | 93 | 95 | $19,000 | $6,289 | 33.1% |
About Dr. David Kim, M.D
Dr. David Kim, M.D is a Specialist healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700992534.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Kim, M.D has received a total of $3,057 in payments from pharmaceutical and medical device companies, with $216.52 received in 2024. These payments were reported across 172 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($2,734).
As a Medicare-enrolled provider, Kim has provided services to 7,247 Medicare beneficiaries, totaling 11,949 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Torrance, CA
- Active Since 08/22/2006
- Last Updated 03/19/2024
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700992534
Products in Payments
- CLENPIQ (Drug) $612.12
- Linzess (Drug) $548.16
- PREPOPIK (Drug) $416.16
- SUTAB (Drug) $322.56
- LINZESS (Drug) $294.85
- Creon (Drug) $240.66
- VIBERZI (Drug) $229.44
- SUFLAVE (Drug) $127.27
- Vemlidy (Drug) $125.00
- CREON (Drug) $74.32
- INTERSTIM (Device) $16.73
- Ozempic (Drug) $14.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Torrance
Dr. William Kim, M.d, M.D
Specialist — Payments: $167,651
Specialist $167,651
Dr. Peter Borden, Md, MD
Specialist — Payments: $88,354
Specialist $88,354
Dr. Sutha Sachar, Md, MD
Specialist — Payments: $23,126
Specialist $23,126
Michael Arnstein, M.d, M.D
Specialist — Payments: $13,983
Specialist $13,983
Dr. Hala Koudsi, M.d, M.D
Specialist — Payments: $9,366
Specialist $9,366
Dr. Munish Lal, Md, MD
Specialist — Payments: $6,495
Specialist $6,495